These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34642021)

  • 1. Regional citrate anticoagulation high-cut-off continuous veno-venous hemodialysis for COVID-19 and AKI patients in intensive care unit.
    Nalesso F; Gobbi L; Cattarin L; Innico G; Calò LA
    Clin Nephrol; 2021 Dec; 96(6):363-364. PubMed ID: 34642021
    [No Abstract]   [Full Text] [Related]  

  • 2. Feasibility and safety of combined cytokine adsorption and continuous veno-venous hemodialysis with regional citrate anticoagulation in patients with septic shock.
    Dimski T; Brandenburger T; Slowinski T; Kindgen-Milles D
    Int J Artif Organs; 2020 Jan; 43(1):10-16. PubMed ID: 31379256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous hemodialysis with citrate anticoagulation and standard dialysate for managing acute kidney injury in patients with moderate to severe hyponatremia-A retrospective study.
    Hellman T; Uusalo P; Järvisalo MJ
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):778-784. PubMed ID: 33595109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons for the clinical nephrologist: vascular access recirculation during continuous renal replacement therapy and regional citrate anticoagulation.
    Scherer PF; Barbeiro BG; Ammirati AL; Dos Santos BFC; Monte JCM; Batista MC; Doher MP; Dos Santos OFP; Matsui TN; Gonçalves VP; de Souza Durão M
    J Nephrol; 2023 Mar; 36(2):335-339. PubMed ID: 35994231
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation.
    Margraf A; Liu C; Küllmar M; Meersch M; Rossaint J; Zarbock A
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial.
    Weidhase L; Haussig E; Haussig S; Kaiser T; de Fallois J; Petros S
    PLoS One; 2019; 14(4):e0215823. PubMed ID: 31026303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the application of regional citrate anticoagulation in continuous renal replacement therapy in children].
    Li N; Miao XL; Wu BY
    Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):250-253. PubMed ID: 35240750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Continuous Veno-Venous HemoDiALYsis with Regional Citrate Anticoagulation on Non-NUTRItional Calorie Balance in Patients on the ICU-The NUTRI-DAY Study.
    Wechselberger S; Compton F; Schilling J
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
    Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
    BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiautomated Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Observational Study in Young Children.
    Liet JM; Baleine J; Demaret P; Mounier S; Porcheret F; Joram N; Chenouard A
    Pediatr Crit Care Med; 2022 Sep; 23(9):e429-e433. PubMed ID: 35583226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation for continuous renal replacement therapy in the intensive care unit: a comparison of dalteparin infusion with regional citrate anticoagulation].
    Uljas E; Karjalainen M; Vaara S; Reinikainen M
    Duodecim; 2015; 131(11):1079-84. PubMed ID: 26245070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.
    Shankaranarayanan D; Muthukumar T; Barbar T; Bhasin A; Gerardine S; Lamba P; Leuprecht L; Neupane SP; Salinas T; Shimonov D; Varma E; Liu F
    Clin J Am Soc Nephrol; 2020 Dec; 16(1):124-126. PubMed ID: 32943397
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury.
    Costa E Silva VT; Caires RA; Bezerra JS; Costalonga EC; Oliveira APL; Oliveira Coelho F; Fukushima JT; Soares CM; Oikawa L; Hajjar LA; Burdmann EA
    J Crit Care; 2018 Oct; 47():302-309. PubMed ID: 29859647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
    Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
    J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
    Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction.
    De Vico P; Messino V; Tartaglione A; Beccaris C; Buonomo C; Talarico D; Prati P; Sabato AF; Colella DF
    Ther Apher Dial; 2015 Jun; 19(3):272-8. PubMed ID: 25656632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.